Author:
Smyth Andrew,Houlihan Diarmaid D,Tuite Helen,Fleming Catherine,O'Gorman Thomas A
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000, 343: 1586-1593. 10.1056/NEJM200011303432201.
2. Fisher CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Bengamin E: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996, 334: 1697-1702. 10.1056/NEJM199606273342603.
3. O'Dell JR: Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?. N Engl J Med. 1999, 340: 310-312. 10.1056/NEJM199901283400411.
4. Reddy JG, Loftus EV: Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Gastroenterol Clin North Am. 2006, 35: 837-855. 10.1016/j.gtc.2006.09.008.
5. Kavanagh PM, Gilmartin JJ, O'Donnell J, O'Flanagan D: Tumour necrosis factor-alpha and tuberculosis: guidance from the National TB Advisory Committee. Ir Med J. 2008, 101: 6-7.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献